I’m a big fan of growth shares and feel very fortunate to have such a large number to choose from on the Australian share market.
Three ASX growth shares that I think would be top options for investors are listed below. Here’s why I think they could generate outsized returns for investors over the next decade:
IDP Education Ltd (ASX: IEL)
The first growth share to look at is IDP Education. It is a leading provider of international student placement services and English language testing services. Given the closure of borders globally, IDP Education has been impacted negatively by the pandemic. However, with its shares down almost 50% from their 52-week high, I’m confident this is more than priced in now. In light of this, I think now could be an opportune time to invest. Especially given its strong balance sheet and its very positive long term growth outlook.
NEXTDC Ltd (ASX: NXT)
Another growth share to consider buying is NEXTDC. Unlike IDP Education, NEXTDC has been a big winner from the pandemic thanks to the accelerating shift to the cloud. The good news is that there’s still a long way to go for the cloud computing boom. According to global technology research firm Gartner, it has forecast that 80% of all organisations will shift their workloads to third-party data centres by 2025. Overall, I expect this to lead to increasing demand for its innovative data centre outsourcing solutions over the next decade.
ResMed Inc. (ASX: RMD)
A final ASX growth share to consider buying is ResMed. I’m confident the medical device company can continue its solid growth over the next decade thanks to its focus on the sleep treatment market. This lucrative market is growing quickly due to the proliferation of obstructive sleep apnoea and other sleep disorders. And given the quality of its products and software, I believe it is well-positioned to capture a growing slice of this market.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- Earnings preview: What to expect from the NEXTDC FY 2020 result
- Top brokers name 3 ASX 200 shares to buy today
- 3 ASX shares fighting COVID-19 and rewarding shareholders
- Has the CSL share price lost its ASX 200 market darling status?
- Where I’d invest $10,000 in ASX shares for the future
James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Idp Education Pty Ltd. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Why I would buy ResMed and these ASX growth shares appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2DRW3v5
Leave a Reply